These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19954406)

  • 1. Perphenazine solid dispersions for orally fast-disintegrating tablets: physical stability and formulation.
    Laitinen R; Suihko E; Bjorkqvist M; Riikonen J; Lehto VP; Jarvinen K; Ketolainen J
    Drug Dev Ind Pharm; 2010 May; 36(5):601-13. PubMed ID: 19954406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
    Wang L; Zeng F; Zong L
    Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of orally disintegrating tablets of perphenazine/hydroxypropyl-beta-cyclodextrin inclusion complex in rabbits.
    Wang L; Xiao YY; Chen ML; Zeng F; Zong L
    Pharmazie; 2013 Oct; 68(10):800-4. PubMed ID: 24273883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraorally fast-dissolving particles of a poorly soluble drug: preparation and in vitro characterization.
    Laitinen R; Suihko E; Toukola K; Björkqvist M; Riikonen J; Lehto VP; Järvinen K; Ketolainen J
    Eur J Pharm Biopharm; 2009 Feb; 71(2):271-81. PubMed ID: 18824096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fast-dissolving sublingual solid dispersion and cyclodextrin complex increase the absorption of perphenazine in rabbits.
    Turunen E; Mannila J; Laitinen R; Riikonen J; Lehto VP; Järvinen T; Ketolainen J; Järvinen K; Jarho P
    J Pharm Pharmacol; 2011 Jan; 63(1):19-25. PubMed ID: 21155811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of storage on the dissolution rate of a fast-dissolving perphenazine/β-cyclodextrin complex.
    Turunen E; Korhonen O; Lehto VP; Kauppinen A; Ahtiainen H; Järvinen K; Jarho P
    J Pharm Pharmacol; 2014 Mar; 66(3):367-77. PubMed ID: 24206258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QbD approach of rapid disintegrating tablets incorporating indomethacin solid dispersion.
    Sammour OA; Hammad MA; Zidan AS; Mowafy AG
    Pharm Dev Technol; 2011 Jun; 16(3):219-27. PubMed ID: 20163325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amorphous nanoparticle complex of perphenazine and dextran sulfate as a new solubility enhancement strategy of antipsychotic perphenazine.
    Dong B; Hadinoto K
    Drug Dev Ind Pharm; 2017 Jun; 43(6):996-1002. PubMed ID: 28121189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of polymer, plasticizer and filler on orally disintegrating film.
    Liew KB; Tan YT; Peh KK
    Drug Dev Ind Pharm; 2014 Jan; 40(1):110-9. PubMed ID: 23311593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants.
    Srinarong P; Faber JH; Visser MR; Hinrichs WL; Frijlink HW
    Eur J Pharm Biopharm; 2009 Sep; 73(1):154-61. PubMed ID: 19465121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral disintegrating tablets. A new, modern, solid dosage form].
    Popa G; Gafiţanu E
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):337-42. PubMed ID: 14755937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of two direct compression lactose grades for pyridoxine hydrochloride tablets.
    Aly SA; Udeala OK
    Pharmazie; 1988 Mar; 43(3):188-90. PubMed ID: 3380861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of tablet formulation based on solid dispersion of glimepiride and poly(ester amide) hyperbranched polymer.
    Reven S; Homar M; Peternel L; Kristl J; Žagar E
    Pharm Dev Technol; 2013; 18(2):323-32. PubMed ID: 21812524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation of Herbal Fast Disintegrating Tablets and its ex-vivo Study for Anti-histaminic Activity in Guinea Pig Ileum.
    Puri D; Bhandari A; Gaur PK; Yasir M; Kumar SS; Choudhary D; Saxena PK
    Curr Clin Pharmacol; 2018; 13(2):128-135. PubMed ID: 29521214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The compression of granulates containing solid dispersions.
    Kinget R; Kemel R
    Pharmazie; 1985 Jul; 40(7):475-7. PubMed ID: 4048252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of an orally fast disintegrating tablet formulation containing a hydrophobic drug.
    Comoglu T; Unal B
    Pharm Dev Technol; 2015 Jan; 20(1):60-4. PubMed ID: 24295202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of dissolution rate of hydrochlorothiazide via solid dispersion.
    Abd el-Fattah S; Boraie NA; Hassan HM
    Pharmazie; 1986 Nov; 41(11):790-3. PubMed ID: 3562513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of the SeDeM Diagram expert system to determine the suitability of diluents-disintegrants for direct compression and their use in formulation of ODT.
    Aguilar-Díaz JE; García-Montoya E; Pérez-Lozano P; Suñe-Negre JM; Miñarro M; Ticó JR
    Eur J Pharm Biopharm; 2009 Nov; 73(3):414-23. PubMed ID: 19602435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.